LPL Financial LLC

Position in CLLS — Cellectis S.A.

CIK 1403438 FORT MILL, SC

Position in CLLS

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$267,373

-$143,020 QoQ

Shares Held

84,345

-0.5% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. CLLS ranks #107 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$267,373	84,345	-0.5%	Shares	Sole	2026-05-06
2025-12-31	$410,393	84,792	-0.4%	Shares	Sole	2026-02-11
2025-09-30	$242,668	85,147	-0.6%	Shares	Sole	2025-11-12
2025-06-30	$130,634	85,662	+1.1%	Shares	Sole	2025-08-12
2025-03-31	$105,086	84,747	-0.6%	Shares	Sole	2025-05-07
2024-12-31	$153,489	85,272	-7.7%	Shares	Sole	2025-02-11
2024-09-30	$195,828	92,372	+0.6%	Shares	Sole	2024-11-08
2024-06-30	$171,641	91,787	+12.8%	Shares	Sole	2024-08-07
2024-03-31	$215,569	81,347	+12.7%	Shares	Sole	2024-05-10
2023-12-31	$222,335	72,187	+13.4%	Shares	Sole	2024-02-14
2023-09-30	$100,578	63,657	+354.5%	Shares	Sole	2023-11-13
2023-06-30	$27,565	14,007	+13.4%	Shares	Sole	2023-07-31
2023-03-31	$23,849	12,357	-24.0%	Shares	Sole	2023-05-10
2020-12-31	$439,752	16,251	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.